Home Photos Surgery Types Cosmetic Surgeons Surgery Prices Surgery Risks Plastic Surgery News

Controversial obesity drug gets UK okay (Reuters)

Subway riders walk through the turnstiles while leaving the U.S. Open in New York September 4, 2007. (Lucas Jackson/Reuters)Reuters - Sanofi-Aventis won a final green light for its obesity drug Acomplia from Britain’s cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health service.


More: continued here





You can respond, or trackback from your own site.


Related News

  • Sanofi obesity drug faces tough EU safety review (Reuters)
  • Sanofi-Aventis withdraws anti-obesity drug from sale in Europe (AFP)
  • Sanofi withdraws anti-obesity drug in US (AFP)
  • Key US drug panel rejects Sanofi's obesity pill (AFP)
  • Sanofi pulls obesity drug application in U.S. (Reuters)
  • Panel rejects new weight-loss drug (AP)
  • Panel rejects Sanofi obesity drug (Reuters)
  • Obesity ops refused on cost grounds (Liverpool Echo)
  • Obesity drug has little effect on heart in teens (Reuters)
  • Doctor calls obesity surgery "single most powerful" health remedy - calls for more funding


    • Leave a Reply
    Cosmetic Surgery Procedure.com | Cosmetic Surgery Types | Find a Cosmetic Surgeon | Cosmetic Surgery Prices | Cosmetic Surgery Risks | Resources | Contact Us